This inventor holds 3 USPTO granted patents. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: The Innovations of Pier Paolo DiFiore
Introduction
Pier Paolo DiFiore is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biomedical research, particularly in the area of epidermal growth factor receptors. With a total of 3 patents, his work has advanced our understanding of cellular processes and potential therapeutic targets.
Latest Patents
DiFiore's latest patents include groundbreaking innovations such as antibodies drawn to the eps15 substrate for epidermal growth factor. This patent describes a new substrate of the epidermal growth factor receptor and certain other tyrosine kinase receptors denominated eps15. It also covers polynucleotides encoding eps15, antisense eps15 polynucleotide, triple helix eps15 polynucleotide, antibodies to eps15, and assays for determining eps15. Another significant patent focuses on the substrate for the epidermal growth factor receptor kinase, reiterating the importance of eps15 in cellular signaling pathways.
Career Highlights
DiFiore works for the United States of America as represented by the Department of Health. His role in this esteemed organization allows him to contribute to vital health-related research and innovation. His expertise in the field has positioned him as a key figure in advancing medical science.
Collaborations
One of his notable collaborators is Francesca Fazioli. Together, they have worked on various projects that aim to enhance our understanding of cellular mechanisms and develop new therapeutic strategies.
Conclusion
Pier Paolo DiFiore's contributions to the field of biomedical research through his patents and collaborations highlight his commitment to innovation. His work continues to pave the way for advancements in health and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
